Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Aequus Pharmaceuticals (AQS.V), a Canadian-based specialty pharma company with products for treatment of Ophthalmological conditions as well as solutions for human organ transplants, neurological disorders, epilepsy as well as anti-nausea applications.

Enjoy!